Metabolomics Analysis — Metabolome Profiling
Metabolomics Data Analysis · Also known as: metabolome profiling, metabolic profiling, metabonomics, metabolite profiling
Metabolomics analysis is the large-scale, systematic measurement of small-molecule metabolites in a biological sample to characterise the metabolome — the complete set of metabolic intermediates and products present under defined conditions. By coupling high-throughput analytical platforms such as mass spectrometry (MS) or nuclear magnetic resonance (NMR) spectroscopy with multivariate statistics and pathway databases, metabolomics bridges the genotype–phenotype gap and captures the downstream functional output of genes, transcripts, and proteins in real time.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
+4 more
When to use it
Use metabolomics analysis when the research question concerns the functional metabolic state of a biological system — for example, identifying biomarkers of disease, characterising the metabolic response to drug treatment, diet, or environmental stress, or understanding metabolic reprogramming in cancer or metabolic syndrome. It is the appropriate choice when downstream phenotypic outcomes are more informative than upstream gene or protein measurements alone. Do not use it as a substitute for targeted clinical assays when only a small number of known metabolites need to be quantified with regulatory-grade accuracy. Avoid untargeted metabolomics if sample quality cannot be standardised (e.g., freeze-thaw cycles, variable collection timing), as pre-analytical variation dominates biological signal. It is not suitable when the biological question requires single-cell resolution — bulk metabolomics reports average concentrations across a cell population.
Strengths & limitations
- Captures the functional phenotype of a biological system in a single experiment, integrating genetic, epigenetic, and environmental influences.
- Both hypothesis-free (untargeted) and hypothesis-driven (targeted) modes are available within the same analytical framework.
- Metabolites are closer to the phenotype than genes or transcripts, making metabolomics highly sensitive to physiological perturbations.
- Mature, freely available software (MetaboAnalyst, XCMS, MZmine) and comprehensive databases (HMDB, METLIN, KEGG) support end-to-end analysis.
- Compatible with non-invasive or minimally invasive sample types such as urine, saliva, and exhaled breath condensate.
- The metabolome is highly dynamic and sensitive to pre-analytical variables — sample collection time, diet, physical activity, and storage conditions introduce substantial confounding.
- Annotation remains incomplete: in untargeted studies, 30–70% of detected features typically cannot be confidently identified, limiting biological interpretation.
- No single analytical platform covers the entire metabolome; LC-MS, GC-MS, and NMR each detect complementary but non-overlapping subsets of metabolites.
- High-dimensional data with many more features than samples creates overfitting risk in supervised models; rigorous cross-validation is mandatory.
- Absolute quantification requires isotope-labelled internal standards for every target metabolite, which is expensive and limits untargeted discovery studies.
Frequently asked
What is the difference between untargeted and targeted metabolomics?
Untargeted metabolomics aims to detect as many metabolite features as possible in an unbiased, discovery-oriented manner, typically yielding hundreds to thousands of features with variable annotation confidence. Targeted metabolomics quantifies a pre-defined set of metabolites — often 20 to a few hundred — using authentic standards, providing accurate absolute concentrations but no discovery potential beyond the target panel. Most studies use untargeted profiling for discovery followed by targeted validation of key findings.
How many samples do I need for a metabolomics study?
Statistical power in metabolomics depends on the effect size and the false-discovery rate correction burden imposed by thousands of features. A minimum of 10 samples per group is often cited for pilot work, but adequately powered studies typically require 20–50 or more subjects per group. Formal power calculations are complicated by the high dimensionality; simulation-based approaches or existing pilot data should guide sample-size decisions.
Is NMR or mass spectrometry better for metabolomics?
Neither platform dominates universally. NMR provides excellent reproducibility, requires minimal sample preparation, and enables absolute quantification without standards, but has lower sensitivity and detects fewer metabolites (typically 30–100). LC-MS offers far greater sensitivity and metabolite coverage (hundreds to thousands of features) but requires more complex preprocessing and is prone to matrix effects. GC-MS is optimal for volatile, derivatisable metabolites such as organic acids and amino acids. Many studies combine platforms to maximise coverage.
Can I integrate metabolomics with transcriptomics or proteomics?
Yes — multi-omics integration is a major application of metabolomics. Tools such as MOFA+, MixOmics, and network-based approaches combine metabolomics data with transcriptomics (RNA-seq) and proteomics to identify coordinated molecular programmes. Such integration increases interpretability but also analytical complexity; data matrices from different platforms must be carefully normalised and the integration model validated to avoid spurious cross-layer correlations.
What databases and software should I use?
The most widely used open-source tools are: XCMS or MZmine for LC-MS peak detection and alignment; MetaboAnalyst (web platform) for statistical analysis and pathway enrichment; and HMDB or METLIN for metabolite annotation. For NMR, Chenomx NMR Suite and rNMR are common. Pathway analysis relies on KEGG, Reactome, and MetaCyc. For multi-omics integration, MixOmics and MOFA+ are well-established R/Python packages.
Sources
- Fiehn, O. (2002). Metabolomics — the link between genotypes and phenotypes. Plant Molecular Biology, 48(1-2), 155–171. link ↗
- Wishart, D. S., et al. (2022). HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Research, 50(D1), D622–D631. DOI: 10.1093/nar/gkab1062 ↗
How to cite this page
ScholarGate. (2026, June 3). Metabolomics Data Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/metabolomics-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- eQTL AnalysisBioinformatics↔ compare
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- Multi-omics metabolomics analysisBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- Proteomics AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare